trending Market Intelligence /marketintelligence/en/news-insights/trending/a8sL0u0Js2_7Wsp0cKLGNg2 content esgSubNav
In This List

Jaguar Animal Health completes merger with Napo Pharmaceuticals

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Jaguar Animal Health completes merger with Napo Pharmaceuticals

Jaguar Animal Health Inc. completed its merger with Napo Pharmaceuticals Inc. and changed its name to Jaguar Health Inc.

Napo has started operating as a unit of Jaguar focused on human health and the ongoing commercialization of Mytesi, which is approved by the U.S. Food and Drug Administration for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar said it will continue trading under the Nasdaq ticker symbol JAGX.